22q In the News
You are here
As part of its mission to promote awareness regarding 22q11.2 deletion syndrome, The 22q Family Foundation strives to provide timely content from credible sources through channels that include but are not limited to this website. All content is made available for information purposes only. The Foundation gives no assurance or warranty, nor makes any endorsement or other representation, as to the accuracy, completeness, or validity of such content. Each person accessing this site is responsible for making his/her own assessment of the information provided.
"The use of NIPT to detect common fetal chromosomal abnormalities is increasing, yet we found significant rates of false positive test results after subsequent follow-up testing with microarray and karyotyping," said Dr. Sahoo
- 1 of 8
- next ›